# Intra-articular Tranexamic Acid in the Reduction of Blood Transfusions in Primary Total Hip and Total Knee Arthroplasty

> **NCT02393963** · PHASE2 · COMPLETED · sponsor: **Orthopaedic Innovation Centre** · enrollment: 140 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Tranexamic Acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02393963
- **Lead sponsor:** Orthopaedic Innovation Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-07
- **Final completion:** 2016-12-21
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2017-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02393963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02393963, "Intra-articular Tranexamic Acid in the Reduction of Blood Transfusions in Primary Total Hip and Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02393963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*